Bank of America shares have maintained an orderly upward grind through July and early August. The stock was changing hands near $64.37 in midday trading on August 12, 2026, compared with $59.50 at the July 13 close, a gain of approximately 8.2% over roughly 30 days. The advance has been supported by a strong second-quarter earnings season for large U.S. banks, resilient consumer spending, and an improving investment-banking and trading backdrop. Financial-sector sentiment has also benefited from rebounding capital-markets activity and broadly stable credit trends. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Bank of America Corporation is a diversified financial services company headquartered in Charlotte, North Carolina. The bank operates through Consumer Banking, Global Wealth and Investment Management, Global Banking, and Global Markets, serving consumers, small and middle-market businesses, large corporations, governments, and institutional investors. Its offerings span deposits, lending, credit cards, mortgages, wealth management, investment banking, sales and trading, and treasury services.
The company competes with peers such as JPMorgan Chase (JPM), Wells Fargo (WFC), Citigroup (C), and Morgan Stanley (MS). BAC's competitive strengths include a leading deposit franchise, scale across lending and capital markets, strong digital adoption, and a diversified revenue base. The bank has reported 12 consecutive quarters of average deposit growth and maintains relationships with 78% of the Global Fortune 500 and 96% of the U.S. Fortune 1,000. Investors follow the stock for its sensitivity to interest rates, consumer credit trends, capital-markets activity, and shareholder returns.
The central catalyst in the past 30 days was the July 14 second-quarter earnings report. BAC reported EPS of $1.21, above consensus estimates, on revenue of $31.6 billion, up 15% year over year. Net income rose 27% to $9.1 billion. Net interest income increased 9% to about $16.0 billion, while noninterest income climbed 22%. Sales and trading revenue reached $7.2 billion, up 33%, with equities trading rising roughly 70% to a record $3.6 billion. Investment banking fees increased 50% to more than $2.1 billion, and the efficiency ratio improved to 59% with operating leverage of 6.6%.
Credit quality remained stable. The provision for credit losses was approximately $1.4 billion, and the net charge-off ratio improved to 0.47%. The company returned $8.0 billion to shareholders through $6.0 billion in buybacks and $2.0 billion in dividends. Management now expects full-year operating leverage of 300–400 basis points and net interest income growth at the upper end of the 6%–8% range, with guidance assuming a 25-basis-point rate increase in September.
After the report, several analysts lifted targets. UBS reiterated a Buy rating with a $70 price target, Barclays maintained a Buy rating with a $72 target, and JPMorgan raised its target to $68. The consensus rating remains Buy, with average 12-month targets clustering in the high-$60s. Separately, BAC disclosed it may face monetary penalties tied to deficiencies in its anti-money-laundering program, with a potential resolution with the OCC approaching. The bank also continued to highlight AI adoption, citing more than 300 approved AI use cases, 114 live generative AI use cases, and over 200,000 employees using AI-enabled capabilities. From what I see, the breadth of the earnings beat and the raised guidance stand out as particularly supportive.
Looking ahead, investors are likely to monitor third-quarter earnings, net interest income, and the net interest yield as the interest-rate outlook evolves. Management's guidance assumes a September rate increase, and the bank's disclosed sensitivity indicates that a 100-basis-point shift above the forward curve could add about $1.0 billion to net interest income over 12 months, while a 100-basis-point decline could reduce it by about $2.2 billion. Capital-markets pipelines, trading volumes, wealth-management flows, and loan growth will also shape revenue momentum.
Other factors include consumer and commercial credit trends, expense discipline and operating leverage, the resolution of the AML-related regulatory matter with the OCC, and the pace of capital return through buybacks and dividends. AI-driven productivity initiatives remain a strategic theme, while deposit pricing competition and the broader economic backdrop will influence sentiment. These considerations are informational and do not constitute financial advice. I’m watching this closely as the rate path and credit metrics develop.
In my own analysis, I often turn to Tickeron’s AI Trading Bots to explore systematic strategies across different timeframes and performance metrics. The platform helps filter ideas by strategy and consistency, which can provide useful context when evaluating names like BAC alongside broader market signals. It has become a regular part of how I cross-check momentum and pattern ideas without replacing traditional fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
BAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 35 cases where BAC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on September 03, 2026. You may want to consider a long position or call options on BAC as a result. In 50 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
Following a +1.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAC advanced for three days, in 222 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 171 of 288 cases where BAC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The 10-day RSI Indicator for BAC moved out of overbought territory on August 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 25 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Moving Average Convergence Divergence Histogram (MACD) for BAC turned negative on August 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 24 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Tickeron SMR rating for this company is 2 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock slightly worse than average.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating fairly steady price growth. BAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.588) is normal, around the industry mean (1.909). P/E Ratio (14.478) is within average values for comparable stocks, (15.285). Projected Growth (PEG Ratio) (0.947) is also within normal values, averaging (1.343). Dividend Yield (0.019) settles around the average of (0.025) among similar stocks. P/S Ratio (3.945) is also within normal values, averaging (3.939).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks